Synthetic haemophilus influenzae conjugate vaccine

Details Synthetic haemophilus influenzae conjugate vaccine Synthetic haemophilus influenzae conjugate vaccine

C - Chemistry, Metallurgy

07

K

C07K 14/285 (2006.01) A61K 39/102 (2006.01) A61K 39/385 (2006.01) A61K 39/40 (2006.01) A61K 47/48 (2006.01) C07H 15/04 (2006.01) C07H 15/08 (2006.01) C07H 15/18 (2006.01) C07H 15/203 (2006.01) C07K 4/04 (2006.01) C07K 7/08 (2006.01) G01N 33/569 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2129101

Synthetic peptides have an amino acid sequence corresponding to at least one antigenic determinant of at least one protein, usually a structural protein, particularly the P1, P2 and P6 protein, of Haemophilus influenzae (Hi), particularly type b, and are used as is, in chimeric T-B form, in lipidated form, linked to a carrier molecule, particularly a synthetic PRP molecule and/or polymerized to form molecular aggregates, in vaccines against Hi.

Affiliated with

Also associated with

Rating

Synthetic haemophilus influenzae conjugate vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthetic haemophilus influenzae conjugate vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic haemophilus influenzae conjugate vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1613950